drugset / Trial / NCT03660345
PPV With Internal Limiting Membrane Peeling for Treatment-Naïve DME
RandomizedParallel-groupSingle-blindTreatment
Summary
Treatment-naïve subjects with center-involved diabetic macular edema undergoing pars plana vitrectomy with internal limiting membrane peeling will have similar visual outcomes but better anatomical outcomes compared to subjects undergoing intravitreal bevacizumab monotherapy at one year.
Timeline
- Start
- 2018-09-04
- Primary completion
- 2021-05-04
- Completion
- 2021-05-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aflibercept | Protein / enzyme biologic | — | Intravitreal |